Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district
Ennio Polilli,1 Valeria Cento,2 Umberto Restelli,3,4 Francesca Ceccherini-Silberstein,2 Marianna Aragri,2 Velia Chiara Di Maio,2 Antonina Sciacca,1 Fiorenzo Santoleri,5 Paolo Fazii,6 Alberto Costantini,5 Carlo Federico Perno,2 Giustino Parruti1 1Infectious Diseases Unit, Pescara General Hospital, Pe...
Main Authors: | Polilli E, Cento V, Restelli U, Ceccherini-Silberstein F, Aragri M, Di Maio VC, Sciacca A, Santoleri F, Fazii P, Costantini A, Perno CF, Parruti G |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-09-01
|
Series: | ClinicoEconomics and Outcomes Research |
Subjects: | |
Online Access: | https://www.dovepress.com/consequences-of-inaccurate-hepatitis-c-virus-genotyping-on-the-costs-o-peer-reviewed-article-CEOR |
Similar Items
-
Antiviral Therapy for Hepatitis C Virus: Beyond the Standard of Care
by: Leen Delang, et al.
Published: (2010-03-01) -
Overview of HCV Life Cycle with a Special Focus on Current and Possible Future Antiviral Targets
by: Nathalie Alazard-Dany, et al.
Published: (2019-01-01) -
Cost-effectiveness analysis with direct-acting antivirals in a cohort of HCV-infected inmates in Italy
by: Roberto Ravasio, et al.
Published: (2020-12-01) -
New therapies on the horizon for hepatitis C
by: Silvia C Sookoian, MD
Published: (2003-10-01) -
Mechanistic Insights into Translation and Replication of Hepatitis C Virus RNA : Exploring Direct-Acting Antivirals
by: Kumar, Anuj
Published: (2018)